Record Display for the EPA National Library Catalog

RECORD NUMBER: 37 OF 240

OLS Field Name OLS Field Data
Main Title Economic analysis of final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
CORP Author Environmental Protection Agency, Washington, DC. Office of Water.
Publisher U.S. Environmental Protection Agency,
Year Published 1998
Report Number EPA 821-B-98-009
Stock Number PB99-112070
OCLC Number 40296452
Subjects Pharmaceutical industry--Waste disposal--Economic aspects--United States. ; Effluent quality--Economic aspects--United States.
Additional Subjects Drug industry ; Economic analysis ; Water pollution standards ; Water pollution control ; Standards compliance ; Chemical effluents ; Pollution regulations ; Facilities management ; Economic impact ; Water pollution economics ; Costs ; Cost benefit analysis ; Profits ; Market analysis ; International trade ; Social impact ; Equity(Law) ; Administrative procedures ; Air pollution control ; Guidelines ; Pharmaceutical manufacturing ; Regulatory flexibility analysis ; MACT(Maximum Achievable Control Technology)
Internet Access
Description Access URL
http://nepis.epa.gov/Exe/ZyPDF.cgi?Dockey=20002I6I.PDF
http://www.epa.gov/waterscience/guide/pharm/econanal.html
http://yosemite.epa.gov/ee/epa/ria.nsf/vwAN/TS000034CE-01.pdf/$file/TS000034CE-01.pdf
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
EJBD ARCHIVE EPA 821-B-98-009 Headquarters Library/Washington,DC 12/23/2013
EJED  EPA 821/B-98/009 OCSPP Chemical Library/Washington,DC 01/14/2005
EKAM  EPA 821-B-98-009 Region 4 Library/Atlanta,GA 12/18/1998
ELBD  EPA 821-B-98-009 AWBERC Library/Cincinnati,OH 12/04/1998
NTIS  PB99-112070 Most EPA libraries have a fiche copy filed under the call number shown. Check with individual libraries about paper copy. NTIS 01/01/1988
Collation 1 v. (various pagings) : ill. ; 28 cm.
Abstract
This economic analysis (EA) examines compliance costs and economic impacts resulting from the U.S. Environmental Protection Agency's (EPA's) Final Effluent Limitations Guidelines and Standards for the Pharmaceutical Manufacturing Industry Point Source Category. It also investigates the costs and impacts associated with an air rule requiring Maximum Achievable Control Technology (MACT) to control air emissions, both separately and together with the Final Pharmaceutical Industry Effluent Guidelines. The EA estimates the economic effects of compliance with both final rules in terms of total aggregate annualized costs of compliance, facility closures, impacts on firms (likelihood of bankruptcy and effects on profit margins), and impacts on new sources. The EA also investigates secondary impacts on employment and communities, foreign trade, specific demographic groups, and environmental justice. This report includes a Final Regulatory Flexibility Analysis (FRFA) detailing the impacts on small businesses within the pharmaceutical industry to meet the requirements of the Regulatory Flexibility Act (RFA), as amended by the Small Business Regulatory Enforcement Fairness Act (SBREFA). Finally, the EA presents a cost-benefit analysis to meet the requirements of Executive Order 12866 and the Unfunded Mandates Reform Act.
Notes
"Office of Water"--Cover. "July 1998"--Cover. Includes bibliographical references. "EPA 821-B-98-009"--Cover.